Prosecution Insights
Last updated: October 04, 2026

Dugan & Dugan, Pc

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics

6 pending office actions • 3 clients • 5 examiners • 2 art units • 0 of 6 (0%) have an AI response strategy ready

Analysis

Dugan & Dugan, PC operates as a patent law firm with a focus on Biotechnology & Pharmaceuticals. The firm has managed 1219 career applications, establishing a presence in this technical sector. Its resolved allowance rate stands at 70.97 percent, providing a baseline for expected outcomes in its prosecution efforts. This rate reflects the firm's experience in the Biotechnology & Pharmaceuticals field over its career history. The firm's history is a key asset for its clients.

Currently, the firm is managing 2 pending office actions. The average of 3.98 office actions per allowance indicates the typical level of interaction required with patent examiners to reach a final disposition. For clients in the Biotechnology & Pharmaceuticals space, these metrics offer a data-driven view of the firm's prosecution performance. The 1219 career applications and 3.98 average office actions per allowance are essential for assessing the firm's workload and efficiency. These figures provide a transparent look at the firm's results.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1219 apps, methodology: how we score firms)

71.0%
Allowance Rate
n=1219
+0.35σ
Allowance Rate (norm)
n=1219
4.0
OAs to Allowance
n=528
+0.40σ
OAs to Allow (norm)
n=528
1135 days
Time to Allowance
n=528
+12.9pp
Interview Lift
n=1219
28.0%
RCE Rate
n=1219
3.7%
Appeal Rate
n=1219

Rejection Performance (% of received rejections ultimately overcome)

71.2%
§101 Overcome
n=59
69.5%
§102 Overcome
n=279
72.4%
§103 Overcome
n=406
81.1%
§112 Overcome
n=206

Specialization & Scale

H10P, H01L, G01N
Top CPC Subclasses
32%
Top-3 CPC Share
n=1219
2
Practitioners
n=1219
609.5
Apps / Practitioner
n=1219

Portfolio Summary

6
Total Pending OAs
6
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (67%)
0
Medium (0%)
2
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (33%)
Double-patenting only2 (33%)
Multi-statute (no §101)2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
17% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
17% of docket
0
Mechanical / Eng
0% of docket
4
Business / Other
67% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEGESSE, NINI F 2 68.6% +15.3%
PATEL, JAYESH A 1 83.7% +4.9%
YUN, JURIE 1 87.4% +10.2%
OAKES, JUSTIN MONTGOMERY 1 — —
MARCSISIN, ELLEN JEAN 1 34.5% +49.3%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18998437 ARTIFICIAL INTELLIGENCE TRAINING SYSTEM FOR MEDICAL APPLICATIONS AND METHOD PATEL, JAYESH A —
18864516 ARRAY OF LIGHT SOURCES, FOURIER PTYCHOGRAPHIC IMAGING SYSTEM AND METHOD OF PERFORMING FOURIER PTYCHOGRAPHY YUN, JURIE —
18904006 IN-VITRO METHOD FOR DETERMINING A CELL TYPE OF A WHITE BLOOD CELL WITHOUT LABELING OAKES, JUSTIN MONTGOMERY —
18267449 SYSTEM AND METHOD FOR SIGNAL CALIBRATION IN A SENSOR SYSTEM MARCSISIN, ELLEN JEAN —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
19033479 SYSTEMS AND METHODS FOR MEASURING AND/OR ANALYZING SWING INFORMATION LEGESSE, NINI F —
18864516 ARRAY OF LIGHT SOURCES, FOURIER PTYCHOGRAPHIC IMAGING SYSTEM AND METHOD OF PERFORMING FOURIER PTYCHOGRAPHY YUN, JURIE —
18909938 SYSTEMS AND METHODS FOR MEASURING AND/OR ANALYZING SWING INFORMATION LEGESSE, NINI F —
18267449 SYSTEM AND METHOD FOR SIGNAL CALIBRATION IN A SENSOR SYSTEM MARCSISIN, ELLEN JEAN —

Client Portfolio (3 clients)

Top Art Units

Art UnitApps
28721
16771

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18998437 ARTIFICIAL INTELLIGENCE TRAINING SYSTEM FOR MEDICAL APPLICATIONS AND METHOD Siemens Healthineers AG PATEL, JAYESH A §103§112 Non-Final OA — Pending Jan 24, 2025
19033479 SYSTEMS AND METHODS FOR MEASURING AND/OR ANALYZING SWING INFORMATION Dugan Patents, LLC LEGESSE, NINI F DP Non-Final OA — Pending Jan 21, 2025
18864516 ARRAY OF LIGHT SOURCES, FOURIER PTYCHOGRAPHIC IMAGING SYSTEM AND METHOD OF PERFORMING FOURIER PTYCHOGRAPHY Siemens Healthineers AG YUN, JURIE 2872 §102§103 Non-Final OA — Pending Nov 08, 2024
18909938 SYSTEMS AND METHODS FOR MEASURING AND/OR ANALYZING SWING INFORMATION Dugan Patents, LLC LEGESSE, NINI F DP Non-Final OA — Pending Oct 08, 2024
18904006 IN-VITRO METHOD FOR DETERMINING A CELL TYPE OF A WHITE BLOOD CELL WITHOUT LABELING Siemens Healthineers AG OAKES, JUSTIN MONTGOMERY §101§102§103 Non-Final OA — Pending Oct 01, 2024
18267449 SYSTEM AND METHOD FOR SIGNAL CALIBRATION IN A SENSOR SYSTEM Siemens Healthineers Nederland B.V. MARCSISIN, ELLEN JEAN 1677 §101§103§112 Non-Final OA — Pending Jun 14, 2023

Managing Dugan & Dugan, Pc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month